Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT)

CUSIP: 803607100

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
104,849,534
Total 13F shares
86,798,814
Share change
+3,432,169
Total reported value
$1,674,545,829
Put/Call ratio
112%
Price per share
$19.27
Number of holders
313
Value change
+$92,993,938
Number of buys
170
Number of sells
208

Quarterly Holders Quick Answers

What is CUSIP 803607100?
CUSIP 803607100 identifies SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q3 2025

As of 30 Sep 2025, Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) was held by 313 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 86,798,814 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, Erste Asset Management GmbH, RENAISSANCE TECHNOLOGIES LLC, TWO SIGMA INVESTMENTS, LP, D. E. Shaw & Co., Inc., UBS Group AG, Aberdeen Group plc, and TWO SIGMA ADVISERS, LP. This page lists 313 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.